Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Ligands"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer
Sumi Yun, Yoonjin Kwak, Soo Kyung Nam, An Na Seo, Heung-Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Hye Seung Lee
Cancer Res Treat. 2018;50(4):1351-1361.   Published online January 17, 2018
DOI: https://doi.org/10.4143/crt.2017.487
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Molecular treatments targeting epidermal growth factor receptors (EGFRs) are important strategies for advanced colorectal cancer (CRC). However, clinicopathologic implications of EGFRs and EGFR ligand signaling have not been fully evaluated. We evaluated the expression of EGFR ligands and correlation with their receptors, clinicopathologic factors, and patients’ survival with CRC.
Materials and Methods
The expression of EGFR ligands, including heparin binding epidermal growth factor-like growth factor (HBEGF), transforming growth factor (TGF), betacellulin, and epidermal growth factor (EGF), were evaluated in 331 consecutive CRC samples using mRNA in situ hybridization (ISH). We also evaluated the expression status of EGFR, human epidermal growth factor receptor 2 (HER2), HER3, and HER4 using immunohistochemistry and/or silver ISH.
Results
Unlike low incidences of TGF (38.1%), betacellulin (7.9%), and EGF (2.1%), HBEGF expression was noted in 62.2% of CRC samples. However, the expression of each EGFR ligand did not reveal significant correlations with survival. The combined analyses of EGFR ligands and EGFR expression indicated that the ligands‒/EGFR+ group showed a significant association with the worst disease-free survival (DFS; p=0.018) and overall survival (OS; p=0.005). It was also an independent, unfavorable prognostic factor for DFS (p=0.026) and OS (p=0.007). Additionally, HER4 nuclear expression, regardless of ligand expression, was an independent, favorable prognostic factor for DFS (p=0.034) and OS (p=0.049), by multivariate analysis.
Conclusion
Ligand-independent EGFR overexpression was suggested to have a significant prognostic impact; thus, the expression status of EGFR ligands, in addition to EGFR, might be necessary for predicting patients' outcome in CRC.

Citations

Citations to this article as recorded by  
  • Orthogonal Tri‐Modular Coiled‐Coil Assembly for Programmable Multi‐Cargo Display on Escherichia coli Nissle 1917
    Yong Joon Cho, Gyu‐Jin Lee, Jong‐Ha Park, Sung In Lim
    Small.2026;[Epub]     CrossRef
  • Immune–tumor cell ligand–receptor axes driving metabolic reprogramming and therapeutic resistance in cancer
    Hailin Zhu, Wang Yi, Yujie Wu, Rong Li, Boxuan Zhou
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Advancements in Targeted Therapies for Colorectal Cancer: Overcoming Challenges and Exploring Future Directions
    Said A. Khelwatty, Soozana Puvanenthiran, Alan M. Seddon, Izhar Bagwan, Sharadah Essapen, Helmout Modjtahedi
    Cancers.2025; 17(17): 2810.     CrossRef
  • Gastrin-Releasing Peptide Receptors Stimulate MAPK-Mediated Growth of Lung Cancer Cells by Transactivating HER4 in a Neuregulin-1, MAP Kinase-Dependent Manner Requiring Activation of the ROS-System
    Terry W. Moody, Irene Ramos-Alvarez, Tatiana Iordanskaia, Samuel A. Mantey, Robert T. Jensen
    Biology.2025; 14(9): 1225.     CrossRef
  • Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer
    Harshabad Singh, Ashley Kang, Lisa Bloudek, Ling-I Hsu, Maria Corinna Palanca-Wessels, Michael Stecher, Muriel Siadak, Kimmie Ng
    JNCI Cancer Spectrum.2024;[Epub]     CrossRef
  • Molecular characterization of colorectal mucinous adenocarcinoma and adenocarcinoma, not otherwise specified, identified by multiomic data analysis
    Kailun Xu, Shu Zheng, Baosheng Li, Yingkuan Shao, Xiaoyang Yin
    Frontiers in Molecular Biosciences.2023;[Epub]     CrossRef
  • Mechanism of 5-fluorouracil nanoparticles on releasing skin squamous cell carcinoma through regulation of Wnt/β-catenin expression
    Lixin Peng, Xinping Zhang, Bin Du, Liangliang Sun, Yuguang Zhao
    Materials Express.2022; 12(2): 220.     CrossRef
  • Research on Anti-Tumor Nano-Particle with New Type 5-Fluorouracil on the Peritoneal Metastasis of Breast Cancer
    Yujie Xiao, Guilin Huang, Yibo Xiang
    Journal of Biomaterials and Tissue Engineering.2021; 11(7): 1277.     CrossRef
  • Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
    Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Remus Iulian Nica, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga
    International Journal of Molecular Sciences.2021; 22(19): 10260.     CrossRef
  • SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF
    Weikai Xiao, Shaoquan Zheng, Xinhua Xie, Xing Li, Lijuan Zhang, Anli Yang, Jian Wang, Hailin Tang, Xiaoming Xie
    Molecular Therapy - Oncolytics.2020; 17: 118.     CrossRef
  • Combined Therapeutic Effects of 131I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer


    Pingping Wu, Huayun Zhu, Yan Zhuang, Xiaofeng Sun, Ning Gu
    International Journal of Nanomedicine.2020; Volume 15: 2777.     CrossRef
  • Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon
    Pingping Wu, Qing Zhou, Huayun Zhu, Yan Zhuang, Jun Bao
    BMC Cancer.2020;[Epub]     CrossRef
  • HER4 promotes the progression of colorectal cancer by promoting epithelial‑mesenchymal transition
    Xiaojing Jia, Huien Wang, Zhongxin Li, Jing Yan, Yan Guo, Wujie Zhao, Lixia Gao, Bin Wang, Yitao Jia
    Molecular Medicine Reports.2020;[Epub]     CrossRef
  • Epidermal Growth Factor Receptor: Key to Selective Intracellular Delivery
    A. A. Rosenkranz, T. A. Slastnikova
    Biochemistry (Moscow).2020; 85(9): 967.     CrossRef
  • Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
    Said Abdullah Khelwatty, Sharadah Essapen, Izhar Bagwan, Margaret Green, Alan M. Seddon, Helmout Modjtahedi
    Oncotarget.2019; 10(18): 1704.     CrossRef
  • 12,537 View
  • 220 Download
  • 16 Web of Science
  • 15 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP